ACFN vs MRNA · P/E 22, rev $4.7M vs rev $145.0M
Acorn Energy, Inc. Common Stock (ACFN) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Acorn Energy, Inc. Common Stock (ACFN) is a scientific & technical instruments company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported ACFN revenue for 2026-06-30 was $4.7M. Net income was $217.0K. ACFN currently screens at market cap $43.0M and trailing P/E 22.3.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ACFN currently screens at market cap $43.0M and trailing P/E 22.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ACFN and MRNA stock pages for the full models.
Not investment advice.